According to our new research study on “Organ Preservation Solutions Market Forecast to 2028 — COVID-19 Impact and Analysis — by Solution, Technique, Organ Type, and Geography,” the market is projected to reach US$ 367.26 Million by 2028 from US$ 235.56 Million in 2021; it is expected to register a CAGR of 6.5% during 2021–2028.

The report highlights trends existing in the market, and drivers and hindrances pertaining to the market growth. Factors such as the need for organ transplantation, the prevalence of chronic diseases leading to kidney failure, and growing geriatric population are the key factors driving the market growth.

Get PDF Sample Report + All Related Table and Graphs @: https://www.theinsightpartners.com/sample/TIPHE100001100/

Organ Preservation Solutions Market: Key Insights — Future Trend

Cardiovascular diseases(CVDs) are becoming prevalent worldwide and are becoming a leading cause of death. . According to the American Cardiology College, CVDs contribute to almost 800,000 deaths in the US, that is 1 in every 3 deaths. Most CVD deaths are caused by stroke and heart failure due to coronary heart disease (CHD). According to organdonor.gov, heart transplantation is the third-largest vital organ transplantation procedure performed, after kidney and liver. Technological innovations have been playing a critical role in the widespread use of organ transplantation.

Based on solution, the organ preservation solutions market is segmented into University of Wisconsin solution , custodiol HTK, perfadex, and others. The UW solution segment accounted for the largest market share in 2020. The major use of this solution for the flushing and storage of kidneys, liver, and pancreas is a high request in the segment.

The demand for Perfadex is expected to grow significantly in the coming years, and the projected growth of the market for this segment is ascribed to its wide use in the preservation and perfusion of lungs, making it the gold standard for lung storage.

Organ Preservation Solutions Market: Competitive Landscape and Key Developments: Waters Medical Systems LLC; XVIVO Perfusion; TransMedics, OrganOx Limited; Paragonix Technologies, Inc.; Dr. Franz Koehler Chemie GmbH; Accord Healthcare; 21ST Century medicine; Shanghai Genext Pharmaceutical Technology; and Bridge to Life Ltd.; are among the leading companies operating in the organ preservation solutions market.

Organ Preservation Solutions Market: Segmental Overview

On the basis of solution, the organ preservation solutions market is segmented into University of Wisconsin, solution (UW), custodiol HTK, perfadex, and others.

Based on organ type, the market is segmented into kidneys, liver, lungs, heart, and others. By technique, the market is categorized into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others.

On the basis of geography, the organ preservation solutions market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876